Cataract surgery boosts vision regardless of age-related macular degeneration (AMD) severity, according to a large clinical study published online March 11 in Ophthalmology.
The findings, derived from the Age-Related Eye Disease Study 2 (AREDS2) trial of nutritional supplements in AMD, may help sway clinicians concerned about potential deleterious effects on disease progression, according to Nancy Huynh, MD, from the Clinical Trials Branch, Division of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland, and other members of the AREDS2 Research Group Writing Committee.
"Although accelerated progression to AMD has been reported in population-based studies, our results indicate that cataract surgery is indeed not harmful in persons with AMD," coauthor Emily Y. Chew, MD, deputy director, Division of Epidemiology and Clinical Applications at the National Eye Institute, told Medscape Medical News.
"Cataract surgeons and retinal specialists can look to this very important study to advise patients to consider cataract surgery when appropriate," Damien Luviano, MD, explained to Medscape Medical News, emphasizing the importance of vision improvement in patient functionality and quality of life.